MYOS

MYOS RENS Technology (MYOS)

MYOS RENS Technology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MYOS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/30	06 : 27	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/06/30	06 : 23	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/06/30	06 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/06/22	05 : 07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/06/21	07 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/06/21	07 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/06/21	07 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/06/17	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/05/20	05 : 08	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/05/19	05 : 07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/05/19	05 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/05/16	19 : 04	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/05/02	05 : 49	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/05/02	05 : 32	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/04/29	05 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/04/18	05 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/04/15	05 : 08	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/04/04	05 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/03/16	05 : 33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/03/16	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/03/15	19 : 01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/03/15	05 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/02/15	04 : 07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MYOS	MYOS RENS Technology Inc
2023/01/19	22 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2022/12/07	07 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2022/11/11	07 : 04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MYOS	MYOS RENS Technology Inc
2022/11/11	06 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2022/11/05	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MYOS	MYOS RENS Technology Inc
2022/10/21	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MYOS	MYOS RENS Technology Inc
2022/08/29	19 : 12	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MYOS	MYOS RENS Technology Inc